Skip to main content
OpenTrials

Clinical trial condition

Stage IIIB Breast Cancer

Explore clinical trials studying Stage IIIB Breast Cancer. Study availability and eligibility vary by location and protocol.

103 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIB Breast Cancer trial results

Active, Not Recruiting

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

NCT02445391

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1024 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

NCT02957968

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Virginia Charlottesville, Virginia, United States
  • Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
View Trial Details
Active, Not Recruiting

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

NCT01953588

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 860 locations
View Trial Details
Active, Not Recruiting

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

NCT03971409

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +13 more
Locations
  • O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Chicago Medicine Comprehensive Cancer Center Evergreen Park, Illinois, United States
View Trial Details

Related conditions